Chorioretinitis and vitreitis due to Tropheryma whipplei after transplantation: Case report and review

Transplant Infectious Disease

Volumn 10, Issue 6, 2008, Pages 413-418

  Razonable, R R ^a   Pulido, J S ^a   Deziel, P J ^a   Dev, S ^b   Salomao D R ^a   Walker, R C ^a  

^a MAYO CLINIC   (United States)

^b Minnesota Autism Center   (United States)

Author keywords

Chorioretinitis; Tropheryma whipplei; Vitreitis; Whipple's disease

Indexed keywords

AZATHIOPRINE; CEFTRIAXONE; COTRIMOXAZOLE; DOXYCYCLINE; FLUCONAZOLE; PREDNISONE; VANCOMYCIN; VORICONAZOLE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHORIORETINITIS; CLINICAL FEATURE; CYTOPATHOLOGY; FEMALE; FLUORESCENCE ANGIOGRAPHY; GRAFT FAILURE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE LIPODYSTROPHY; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME; TROPHERYMA WHIPPELII; VITRECTOMY; VITREITIS; VITREOUS BIOPSY; VITREOUS DISEASE;

ANTI-INFECTIVE AGENTS; AZATHIOPRINE; CHORIORETINITIS; DNA, BACTERIAL; DRUG THERAPY, COMBINATION; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL RECESSIVE; POSTOPERATIVE COMPLICATIONS; PREDNISONE; TROPHERYMA; VITREOUS BODY; WHIPPLE DISEASE;

EID: 56549099136     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2008.00322.x     Document Type: Article

References (42)

1. Dutly F, Altwegg M. Whipple's disease and 'Tropheryma whippelii'. Clin Microbiol Rev 2001 14 : 561 583.
2. Fenollar F, Puechal X, Raoult D. Whipple's disease. N Engl J Med 2007 356 : 55 66.
3. Bai JC, Mazure RM, Vazquez H, et al. Whipple's disease. Clin Gastroenterol Hepatol 2004 2 : 849 860.
4. Desnues B, Ihrig M, Raoult D, Mege JL. Whipple's disease: a macrophage disease. Clin Vaccine Immunol 2006 13 : 170 178.
5. Mahnel R, Kalt A, Ring S, Stallmach A, Strober W, Marth T. Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations. Am J Gastroenterol 2005 100 : 1167 1173.
6. Benoit M, Fenollar F, Raoult D, Mege JL. Increased levels of circulating IL-16 and apoptosis markers are related to the activity of Whipple's disease. PLoS ONE 2007 2 : e494.
7. Kneitz C, Suerbaum S, Beer M, Müller J, Jahns R, Tony HP. Exacerbation of Whipple's disease associated with infliximab treatment. Scand J Rheumatol 2005 34 : 148 151.
8. Ramzan NN, Loftus E Jr., Burgart LJ, et al. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med 1997 126 : 520 527.
9. Williams JG, Edward DP, Tessler HH, Pershing DH, Mitchell PS, Goldstein DA. Ocular manifestations of Whipple disease: an atypical presentation. Arch Ophthalmol 1998 116 : 1232 1234.
10. Veys EM, Mielants H. Enteropathic arthritis, uveitis, Whipple's disease, and miscellaneous spondyloarthropathies. Curr Opin Rheumatol 1993 5 : 420 427.
11. Chan RY, Yannuzzi LA, Foster CS. Ocular Whipple's disease: earlier definitive diagnosis. Ophthalmology 2001 108 : 2225 2231.
12. Feurle GE, Volk B, Waldherr R. Cerebral Whipple's disease with negative jejunal histology. N Engl J Med 1979 300 : 907 908.
13. Kalt A, Schneider T, Ring S, et al. Decreased levels of interleukin-12p40 in the serum of patients with Whipple's disease. Int J Colorectal Dis 2006 21 : 114 120. Epub 2005 May 5.
14. Fenollar F, Raoult D. Molecular techniques in Whipple's disease. Expert Rev Mol Diagn 2001 1 : 299 309.
15. Relman DA, Schmidt TM, Macdermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992 327 : 293 301.
16. Deriban G, Marth T. Current concepts of immunopathogenesis, diagnosis and therapy in Whipple's disease. Curr Med Chem 2006 13 : 2921 2926.
17. Lepidi H, Fenollar F, Dumler JS, et al. Cardiac valves in patients with Whipple endocarditis: microbiological, molecular, quantitative histologic, and immunohistochemical studies of 5 patients. J Infect Dis 2004 190 : 935 945.
18. Fenollar F, Birg ML, Gauduchon V, Raoult D. Culture of Tropheryma whipplei from human samples: a 3-year experience (1999 to 2002). J Clin Microbiol 2003 41 : 3816 3822.
19. Drancourt M, Raoult D, Lepidi H, et al. Culture of Tropheryma whippelii from the vitreous fluid of a patient presenting with unilateral uveitis. Ann Intern Med 2003 139 : 1046 1047.
20. Baisden BL, Lepidi H, Raoult D, Argani P, Yardley JH, Dummler JS. Diagnosis of Whipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue. Am J Clin Pathol 2002 118 : 742 748.
21. Singer R. Diagnosis and treatment of Whipple's disease. Drugs 1998 55 : 699 704.
22. Célard M, de Gevigney G, Mosnier S, et al. Polymerase chain reaction analysis for diagnosis of Tropheryma whippelii infective endocarditis in two patients with no previous evidence of Whipple's disease. Clin Infect Dis 1999 29 : 1348 1349.
23. Lowsky R, Archer GL, Fyles G, et al. Brief report: diagnosis of Whipple's disease by molecular analysis of peripheral blood. N Engl J Med 1994 331 : 1343 1346.
24. Brühlmann P, Michel BA, Altwegg M. Diagnosis and therapy monitoring of Whipple's arthritis by polymerase chain reaction. Rheumatology (Oxford) 2000 39 : 1427 1428.
25. Lange U, Teichmann J. Diagnosis of Whipple's disease by molecular analysis of synovial fluid. Arthritis Rheum 1999 42 : 1777 1778.
26. Cohen L, Berthet K, Dauga C, Thivart L, Pierrot-Deseilligny C. Polymerase chain reaction of cerebrospinal fluid to diagnose Whipple's disease. Lancet 1996 347 : 329.
27. Coria F, Cuadrado N, Velasco C, et al. Whipple's disease with isolated central nervous system symptomatology diagnosed by molecular identification of Tropheryma whippelii in peripheral blood. Neurologia 2000 15 : 173 176.
28. Delanty N, Georgescu L, Lynch T, Paget S, Stübgen JP. Synovial fluid polymerase chain reaction as an aid to the diagnosis of central nervous system Whipple's disease. Ann Neurol 1999 45 : 137 138.
29. Lynch T, Odel J, Fredericks DN, et al. Polymerase chain reaction-based detection of Tropheryma whippelii in central nervous system Whipple's disease. Ann Neurol 1997 42 : 120 124.
30. Papadopoulou M, Rentzos M, Nicolaou C, Ioannidou V, Ioannidis A, Chatzipanagiotou S. Cerebral Whipple's disease diagnosed using PCR: the first case reported from Greece. Mol Diagn 2003 7 : 209 211.
31. Rickman LS, Freeman WR, Green WR, et al. Brief report: uveitis caused by Tropheryma whippelii (Whipple's bacillus). N Engl J Med 1995 332 : 363 366.
32. Gras E, Matias-Guiu X, Garcia A, et al. PCR analysis in the pathological diagnosis of Whipple's disease: emphasis on extraintestinal involvement or atypical morphological features. J Pathol 1999 188 : 318 321.
33. Wendler D, Mendoza E, Schleiffer T, Zander M, Maier M. Tropheryma whippelii endocarditis confirmed by polymerase chain reaction. Eur Heart J 1995 16 : 424 425.
34. Petrides PE, Müller-Höcker J, Fredricks DN, Relman DA. PCR analysis of T. whippelii DNA in a case of Whipple's disease: effect of antibiotics and correlation with histology. Am J Gastroenterol 1998 93 : 1579 1582.
35. Boulos A, Rolain JM, Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob Agents Chemother 2004 48 : 747 752.
36. Boulos A, Rolain JM, Mallet MN, Raoult D. Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium. J Antimicrob Chemother 2005 55 : 178 181. Epub 2005 Jan 13.
37. Bakkali N, Fenollar F, Rolain JM, Raoult D. Comment on: therapy for Whipple's disease. J Antimicrob Chemother 2008 61 : 968 969. Epub 2008 Feb 5.
38. Knaapen HK, Barrera P. Therapy for Whipple's disease. J Antimicrob Chemother 2007 60 : 457 458. Epub 2007 Jul 10.
39. Feurle GE, Maiwald M, Marth T. Randomized controlled trial of antimicrobial treatment in Whipple's disease. Gastroenterology 2007 132 : A639.
40. Schneider T, Moos V, Loddenkemp C, Marth T, Fenollar F, Raoult D. Whipple's disease: new aspects on pathogenesis and treatment. Lancet Infect Dis 2008 8 : 179 190.
41. Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transpl Infect Dis 2008 10 : 13 18.
42. Eid AJ, Razonable RR. Valganciclovir for the treatment of cytomegalovirus retinitis in patients with AIDS. Expert Rev Ophthalmol 2007 2 : 351.